On April 11, 2023 Pantarhei Bioscience reported that its Director R&D, Iman Schultz, PhD, will attend the 2023 Annual Meeting of the American Association for Cancer Research (AACR) (Free AACR Whitepaper) held in Orlando, Florida (US), April 14-19, and present data on the discovery of the novel promising immunotherapy target ‘ZP3-Cancer’ (Press release, Pantarhei Bioscience, APR 11, 2023, View Source;utm_medium=rss&utm_campaign=annual-meeting-of-the-american-association-for-cancer-research-aacr-april-14-19-2023-orlando-florida-us [SID1234629951]). ZP3-Cancer is highly selectively enriched in cancer, particularly in lung, colorectal, ovarian and prostate cancer.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The AACR (Free AACR Whitepaper) Annual Meeting covers the latest breakthroughs in cancer, from early discoveries to late stage clinical trials, and attracts top speakers in the field from all over the world.
Looking forward to presenting our data in Orlando.